Belpointe Asset Management LLC - VIR BIOTECHNOLOGY INC ownership

VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 162 filers reported holding VIR BIOTECHNOLOGY INC in Q1 2021. The put-call ratio across all filers is 1.04 and the average weighting 0.4%.

Quarter-by-quarter ownership
Belpointe Asset Management LLC ownership history of VIR BIOTECHNOLOGY INC
ValueSharesWeighting
Q1 2023$4,119
+64.4%
177
+78.8%
0.00%
Q4 2022$2,506
-99.8%
99
-99.6%
0.00%
-100.0%
Q3 2021$1,092,000
+98.2%
25,099
+22.1%
0.07%
+51.0%
Q4 2020$551,00020,5590.05%
Other shareholders
VIR BIOTECHNOLOGY INC shareholders Q1 2021
NameSharesValueWeighting ↓
Bill & Melinda Gates Foundation 1,559,142$40,100,00021.56%
SB INVESTMENT ADVISERS (UK) LTD 22,216,644$571,412,0002.71%
Nan Fung Group Holdings Ltd 210,563$5,416,0002.57%
Taikang Asset Management (Hong Kong) Co Ltd 533,332$13,717,0002.34%
Crawford Lake Capital Management, LLC 168,200$4,326,0001.80%
BOULDER HILL CAPITAL MANAGEMENT LP 126,900$3,264,0001.75%
Zebra Capital Management LLC 22,227$572,0001.31%
Alaska Permanent Fund Corp 2,300,000$59,156,0000.98%
CLARK ESTATES INC/NY 180,000$4,630,0000.73%
Temasek Holdings (Private) Ltd 5,602,553$144,097,6630.61%
View complete list of VIR BIOTECHNOLOGY INC shareholders